Philosophy of Care
Dr. Yang has received extensive training in all aspects of surgical oncology including fellowship training in both clinical surgical oncology and cancer research.
His clinical interests include gastrointestinal malignancies including hepatobiliary and pancreatic malignancies, melanoma, breast cancer, and endocrine diseases such as thyroid, parathyroid and adrenal disease.
Dr. Yang utilizes many of the latest surgical techniques into his practice including sentinel lymph node biopsy for breast cancer and melanoma, minimally invasive/laparoscopic abdominal tumor surgery, and minimally invasive thyroidectomy and parathyroidectomy.
Dr. Yang’s research interests have most recently involved advancing care in the treatment of patients with pancreatic cancer and melanoma. He has previously performed research on mechanisms of signaling and metastasis in pancreatic and colorectal cancer.
4501 X St.
Sacramento, CA 95817
S.B., Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts, 1998
The University of Texas, MD Anderson Cancer Center, Houston, TX, 2009-2011
General Surgery, 2010
Association for Academic Surgery
Society of Surgical Oncology
Honors and Awards:
Allen B. Kanavel Surgical Scholars Award, Northwestern University Feinberg School of Medicine, 2007
Harvey Baker Travelling Fellow Award, Society of Surgical Oncology, 59th Annual Cancer Symposium, 2006
Trainee Travel Award, The 8th International Symposium on Anti-Angiogenic Agents., 2006
ASCO Foundation Merit Award, American Society of Clinical Oncology – Gastrointestinal Cancers Symposium, 2006
Scholarship for American Association for Cancer Research – Molecular Biology in Clinical Oncology Workshop, 2005
Select Recent Publications:
Yang AD, Brouquet, A, Vauthey JN. "Extending Limits of Resection for Metastatic Colorectal Cancer: Risk Benefit Ratio."Journal of Surgical Oncology. 2010 Dec 15;102(8):996-1001.
Van Buren G 2nd, Yang AD, Dallas N, Gray MJ, Lim, SJ, Xia L, Fan F, Somcio R, Wu Y, Hicklin DJ, Ellis LM. "Effect of Molecular Therapeutics on Liver Regeneration in a Murine Model." Journal of Clinical Oncology. 2008; 26(11):1836-42.
Gray MJ, Van Buren G, Dallas NA, Xia L, Wang X, Yang AD, Somcio RJ, Lin YG, Lim S, Fan F, Mangala LS, Arumugam T, Logsdon CD, Lopez-Berestein G, Sood AK, Ellis LM. "Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver." Journal of the National Cancer Institute. 2008; 100(2):109-20; comment 81-3.
Van Buren G 2nd, Rashid A, Yang AD, Abdalla EK, Gray MJ, Liu W, Somcio R, Camp ER, Yao JC, Ellis LM. "The development and characterization of a human midgut carcinoid cell line." Clinical Cancer Research. 2007; 13(16):4704-12.
Yang AD, Melstrom LG, Bentrem DJ, Ujiki MB, Wayne JD, Strouch M, Bell RH, Rao SM, Talamonti SM. "Outcomes after pancreatectomy for intraductal papillary mucinous neoplasms of the pancreas – an institutional experience." Surgery. 2007; 142(4):529-34; discussion 534-7.
Yang AD, Camp ER, Fan F, Shen L, Gray MJ, Liu W, Somcio R, Bauer TW, Wu Y, Hicklin DJ, Ellis LM. “Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.” Cancer Research. 2006; 66(1):46-51.
Yang AD, Fan F, Camp ER, van Buren G, Liu W, Somcio R, Gray MJ, Cheng H, Hoff PM, Ellis LM. “Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines” Clinical Cancer Research. 2006; 12(14 Pt 1):4147-53.
Yang AD, Camp ER, Somcio R, Liu W, Fan F, Ellis LM. “Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.” [Review] Cancer. 2005; 103(8):1561-70.
Yang AD, Bentrem DJ, Pappas SG, Amundsen E, Ward JE, Ujiki MB, Angelos P. “Advance directive use among patients undergoing high-risk operations.” American Journal of Surgery. 188(1): 98-101, 2004 Jul.